Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Long Term Outcomes after Autologous Stem Cell Transplantation for Peripheral T Cell Lymphomas

Deepa Jagadeesh, MD MPH, Lisa Rybicki, MS, Donna M Abounader, Brian T. Hill, MD PhD, Robert M Dean, MD, Hien K. Duong, MD, Ronald M. Sobecks, MD, Betty K. Hamilton, MD, Aaron Gerds, MDMS, Christina Ferraro, RN, BSN, Gina Green, RN, Kelly Cherni, RN, Brad Pohlman, MD, Matt E. Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS

Blood (2014) 124 (21): 1200.

https://doi.org/10.1182/blood.V124.21.1200.1200

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation for Follicular Lymphoma in the Era of Rutiximab: Cleveland Clinic Experience

Blood (2014) 124 (21): 1201.

https://doi.org/10.1182/blood.V124.21.1201.1201

Published: 2014

Journal Articles

Long-Term Outcome Of Adolescents and Young Adults (AYA) After Autologous Transplantation For Lymphoma; Single Center Experience With Bu-CY-VP16 Conditioning Therapy

Rabi Hanna, MD, Brian J. Bolwell, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Deepa Jagadeesh, MD, MPH, Hien K. Duong, MD, Brian T. Hill, MD, PhD, Kelly Cherni, RN, Christina Ferraro, RN, Gina Green, RN, Betty K. Hamilton, MD, Lisa Rybicki, MS, Matt Kalaycio, MD

Blood (2013) 122 (21): 4644.

https://doi.org/10.1182/blood.V122.21.4644.4644

Published: 2013

Journal Articles

A Randomized Study Of Music Therapy In Patients Undergoing Autologous Stem Cell Transplant: Decrease In Narcotic Medication Use For Pain Control

Blood (2013) 122 (21): 1693.

https://doi.org/10.1182/blood.V122.21.1693.1693

Published: 2013

Journal Articles

Non-Relapse Mortality (NRM) after Autologous Stem Cell Transplant (ASCT) Is Reduced with Stringent Follow-up Post-Transplant.

Christy Stotler, DO, Lisa Rybicki, Matt Kalaycio, MD, Robert Dean, Edward A. Copelan, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Steven Andresen, DO, John Sweetenham, MD, Kelly Cherni, RN, Josephine Chan, Brian J. Bolwell, MD

Blood (2008) 112 (11): 2155.

https://doi.org/10.1182/blood.V112.11.2155.2155

Published: 2008

Journal Articles

Comparison of 200 cGy vs. 400 cGy Total Body Irradiation (TBI) When Used with Fludarabine for Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC AHSCT).

Ronald Sobecks, Robert Dean, Lisa Rybicki, Josephine Chan, Karl Theil, Roger Macklis, Steve Andresen, Matt Kalaycio, Brad Pohlman, Christine Ferraro, Kelly Cherni, Laura Bernhard, John Sweetenham, Edward Copelan, Brian Bolwell

Blood (2007) 110 (11): 2003.

https://doi.org/10.1182/blood.V110.11.2003.2003

Published: 2007

Journal Articles

Non-Relapse Mortality Associated with Autologous Stem Cell Transplant (ASCT).

Christy Stotler, Matt Kalaycio, Robert M. Dean, Ronald Sobecks, Edward A. Copelan, Steven Andresen, Brad Pohlman, John William Sweetenham, Lisa Rybicki, Stacey Brown, Kim Bell, Kelly Cherni, Laura Bernhard, Christina Ferraro, Brian J. Bolwell

Blood (2007) 110 (11): 1671.

https://doi.org/10.1182/blood.V110.11.1671.1671

Published: 2007

Journal Articles

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Ronald Sobecks, MD, Karl Theil, MD, Lisa Rybicki, MS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Mary Serafin, RN, Karen Sands, RN, Jennifer Kosar, RN, Brian J. Bolwell, MD

Blood (2006) 108 (11): 2960.

https://doi.org/10.1182/blood.V108.11.2960.2960

Published: 2006

Journal Articles

Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).

Ronald Sobecks, MD, Edward J. Ball, PhD, Medhat Askar, MD, PhD., Karl Theil, MD, Lisa Rybicki, MS, Dawn Thomas, CHS, Jennifer Bates, BS, Matt Kalaycio, MD, Steven Andresen, DO, Brad Pohlman, MD, Robert M. Dean, MD, John William Sweetenham, MD, Laura Bernhard, RN, Kelly Cherni, RN, Jaroslaw P. Maciejewski, MD, MS, Brian J. Bolwell, MD

Blood (2006) 108 (11): 3012.

https://doi.org/10.1182/blood.V108.11.3012.3012

Published: 2006

Journal Articles

Post-Transplant Education Group Increases Patient Knowledge and Confidence.

Jane Dabney, Laura Bernhard, Kelly Cherni, Jennifer Kosar, Mary Serafin, Linda McLellan, Michele Visnosky, Louise Loejos, Julie Curtis, Brian Bolwell

Blood (2006) 108 (11): 3325.

https://doi.org/10.1182/blood.V108.11.3325.3325

Published: 2006

Journal Articles

Patients Mobilizing Large Numbers of CD34+ Cells ("Super-Mobilizers") Have Improved Survival in Autologous Stem Cell Transplantation for Lymphoid Malignancies.

Brian J. Bolwell, MD, Brad Pohlman, MD, Lisa Rybicki, MS, Matt Kalaycio, MD, Ronald Sobecks, MD, Robert M. Dean, MD, Laura Bernhard, RN, Kelly Cherni, RN, Christina Ferraro, RN, Jenny Bates, Stacey Brown, John William Sweetenham, MD

Blood (2006) 108 (11): 3378.

https://doi.org/10.1182/blood.V108.11.3378.3378

Published: 2006

Journal Articles

Comparing Psychosocial Profiles and Outcomes between Patients Undergoing Myeloablative and Non-Myeloablative Allogeneic Transplants.

Linda McLellan, Larry W. Foster, Lisa Rybicki, Jane Dabney, Michele Visnosky, Sungren Sungren, Alison Vellani, Nicole Berry, Kelly Cherni, Laura Bernhard, Jennifer Kosar, Mary Serafin, Karen Sands, Christina Ferraro, Brian J. Bolwell

Blood (2006) 108 (11): 77.

https://doi.org/10.1182/blood.V108.11.77.77

Published: 2006

Journal Articles

Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Rapidly Relapsing Hodgkin’s Disease.

Brian Bolwell, MD, Brad Pohlman, MD, Ronald Sobecks, MD, Steven Andresen, DO, Lisa Rybicki, Stacey Brown, Elizabeth Kuczkowski, Jennifer Bates, Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Matt Kalaycio, M.D.

Blood (2005) 106 (11): 5482.

https://doi.org/10.1182/blood.V106.11.5482.5482

Published: 2005

Journal Articles

Very High Hospital Admission Rate after Outpatient Non-Myeloablative Allogeneic Stem Cell Transplant Using Fludarabine and Low Dose TBI.

Brian Bolwell, MD, Lisa Rybicki, Matt Kalaycio, MD, Brad Pohlman, MD, Steven Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Jennifer Bates, Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Ronald Sobecks, MD

Blood (2005) 106 (11): 3667.

https://doi.org/10.1182/blood.V106.11.3667.3667

Published: 2005

Journal Articles

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

Ronald M. Sobecks, MD, Karl S. Theil, MD, Lisa Rybicki, Roger Macklis, MD, Brad Pohlman, MD, Steve Andresen, DO, Stacey Brown, Elizabeth Kuczkowski, Kelly Cherni, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Matt Kalaycio, MD, Brian Bolwell, MD

Blood (2005) 106 (11): 3674.

https://doi.org/10.1182/blood.V106.11.3674.3674

Published: 2005

Journal Articles

High Dose Therapy with Autologous Blood Stem Cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-Cell (dnDLBL) vs. Transformed, Follicular To Diffuse Large B-Cell Lymphoma (Tdlbl): No Difference in Freedom from Progression.

Brad Pohlman, M.D., Tony Jin, Kristie Summers, Elizabeth Kuczkowski, Stacey Brown, Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Brian J. Bolwell, M.D.

Blood (2004) 104 (11): 1880.

https://doi.org/10.1182/blood.V104.11.1880.1880

Published: 2004

Journal Articles

A Psychosocial Assessment of Patients before and after Autologous Stem Cell Transplantation.

Brian J. Bolwell, M.D., Linda McLellan, LISW, Larry Foster, Ph.D, Jane Dabney, LISW, Erin Welsh, LISW, Elizabeth Kuczkowski, Julie Curtis, R.N., Kimberly Bell, R.N., Janet Baker, R.N., Laura Bernhard, R.N., Kelly Cherni, R.N., Lisa Rybicki, Mikkael A. Sekeres, M.D, M.S.

Blood (2004) 104 (11): 3152.

https://doi.org/10.1182/blood.V104.11.3152.3152

Published: 2004

Journal Articles

The Kinetics of Etoposide (VP-16) Peripheral Blood Progenitor Cell (PBPC) Mobilization.

Brian J. Bolwell, M.D., Elizabeth Kuczkowski, Lisa Rybicki, Brad Pohlman, M.D., Steven Andresen, D.O., Ronald Sobecks, M.D., Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Alison Vellani, Nicole Berry, Shawnda Sungren, Leslie Foster, Matt Kalaycio, M.D.

Blood (2004) 104 (11): 4993.

https://doi.org/10.1182/blood.V104.11.4993.4993

Published: 2004

Journal Articles

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

Brad Pohlman, M.D., Tony Jin, Kristie Summers, Elizabeth Kuczkowski, Matt Kalaycio, M.D., Ronald Sobecks, M.D., Steven Andresen, D.O., Laura Bernhard, R.N., Kelly Cherni, R.N., Janet Baker, R.N., Jennifer Bates, Brian J. Bolwell, M.D.

Blood (2004) 104 (11): 896.

https://doi.org/10.1182/blood.V104.11.896.896

Published: 2004

Journal Articles

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

Brian J. Bolwell, M.D., Brad Pohlman, M.D., Steve Andresen, D.O., Sheila Serafino, Ronald Sobecks, M.D., Elizabeth Kuczkowski, Julie Curtis, R.N., Lisa Rybicki, Jarek Maciejewski, M.D., PhD, Janet Baker, R.N., Kelly Cherni, R.N., Laura Bernhard, R.N., Matt Kalaycio, M.D., Eric Hsi, M.D., Karl Theil, M.D.

Blood (2004) 104 (11): 443.

https://doi.org/10.1182/blood.V104.11.443.443

Published: 2004

NARROW

Long Term Outcomes after Autologous Stem Cell Transplantation for Peripheral T Cell Lymphomas

Autologous Stem Cell Transplantation for Follicular Lymphoma in the Era of Rutiximab: Cleveland Clinic Experience

Long-Term Outcome Of Adolescents and Young Adults (AYA) After Autologous Transplantation For Lymphoma; Single Center Experience With Bu-CY-VP16 Conditioning Therapy

A Randomized Study Of Music Therapy In Patients Undergoing Autologous Stem Cell Transplant: Decrease In Narcotic Medication Use For Pain Control

Non-Relapse Mortality (NRM) after Autologous Stem Cell Transplant (ASCT) Is Reduced with Stringent Follow-up Post-Transplant.

Comparison of 200 cGy vs. 400 cGy Total Body Irradiation (TBI) When Used with Fludarabine for Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC AHSCT).

Non-Relapse Mortality Associated with Autologous Stem Cell Transplant (ASCT).

Comparison of T Cell (CD3+) Chimerism after Myeloablative (MY) and Nonmyeloablative (NM) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT).

Influence of Killer Immunoglobulin-Like Receptor (KIR) Matching on Achieving T Cell (CD3+) Complete Donor Chimerism (CDC) in Related Donor Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).

Post-Transplant Education Group Increases Patient Knowledge and Confidence.

Patients Mobilizing Large Numbers of CD34+ Cells ("Super-Mobilizers") Have Improved Survival in Autologous Stem Cell Transplantation for Lymphoid Malignancies.

Comparing Psychosocial Profiles and Outcomes between Patients Undergoing Myeloablative and Non-Myeloablative Allogeneic Transplants.

Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Rapidly Relapsing Hodgkin’s Disease.

Very High Hospital Admission Rate after Outpatient Non-Myeloablative Allogeneic Stem Cell Transplant Using Fludarabine and Low Dose TBI.

Improved Post-Transplant Outcomes in Hematologic Malignancy Patients Undergoing Non-Myeloablative Hematopoietic Stem Cell Transplant (NMHSCT) Using a 400 cGy Total Body Irradiation (TBI) Dose with Fludarabine.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-Cell (dnDLBL) vs. Transformed, Follicular To Diffuse Large B-Cell Lymphoma (Tdlbl): No Difference in Freedom from Progression.

A Psychosocial Assessment of Patients before and after Autologous Stem Cell Transplantation.

The Kinetics of Etoposide (VP-16) Peripheral Blood Progenitor Cell (PBPC) Mobilization.

High Dose Therapy with Autologous Blood Stem Cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.

The Prognostic Importance of Pre and Post Dendritic Cells in Autologous Transplantation for Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only